Fifth Lane Capital’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Fifth Lane Capital’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25,000	Closed	-$101K	–	206
2023 Q4	$101K	Buy	+25,000	New	+$76.3K	0.12%	35

Fifth Lane Capital's THRX Position: Q1 2024 in Review

Fifth Lane Capital sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 25,000 shares — an estimated $101K sold.

Fifth Lane Capital first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $101K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Fifth Lane Capital reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Fifth Lane Capital sold 25,000 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $101K.
Fifth Lane Capital first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Fifth Lane Capital's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $101K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Fifth Lane Capital's 13F filing for Q1 2024, filed 2 May 2024.